Friday, January 19, 2007

Novartis Strategic Healthcare Portfolio Drives Sustained Strong ...
PharmaLive.com (press release) - Newtown,PA,USA
Beyond these new launches, a number of key compounds are already in or are moving into pivotal late-stage trials, including FTY720 (multiple sclerosis), ...

0 Comments:

Post a Comment

<< Home